LIFECORE BIOMEDICAL, INC. DE
LIFECORE BIOMEDICAL, INC. DE (LFCR): 32 pipeline candidates · ~12 mo cash runway. Updated within the last hour.
BioSniper Score
3-factor signal · derived from public data
12.4 months
D/E -7.20 · 0% dilution
N/A
32 candidates
N/A
N/A
A transparent, data-derived signal for LIFECORE BIOMEDICAL, INC. DEacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$199.9M
Cash
$20.8M
Quarterly Burn
$9.1M
Runway
12.4 mo
Revenue
$23.2M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (32 candidates)
Showing 10 of 32 candidates. Sign up for full pipeline.
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
104
Total value held
$82.7M
| Holder | Shares | Value |
|---|---|---|
| 22nw, lp | 1,254 | $18.9M |
| greenhaven road investment management, l.p. | 3,537,573 | $13.2M |
| vanguard capital management llc | 2,580,272 | $9.6M |
| 325 capital llc | 2,162,466 | $8.0M |
| blackrock, inc. | 1,877,305 | $7.0M |
| grizzlyrock capital, llc | 827,488 | $3.1M |
| geode capital management, llc | 815,107 | $3.0M |
| morgan stanley | 764,734 | $2.8M |
| state street corp | 642,006 | $2.4M |
| quinn opportunity partners llc | 453,495 | $1.7M |
Showing top 10 of 104 institutional holders of LIFECORE BIOMEDICAL, INC. DE. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in LIFECORE BIOMEDICAL, INC. DE's pipeline?
LIFECORE BIOMEDICAL, INC. DE (LFCR) has 32 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is LIFECORE BIOMEDICAL, INC. DE's cash runway?
Based on its most recent reported cash balance and quarterly burn rate, LIFECORE BIOMEDICAL, INC. DE has approximately 12.4 months of cash runway.
What is LIFECORE BIOMEDICAL, INC. DE's market capitalization?
LIFECORE BIOMEDICAL, INC. DE's market capitalization is approximately $199.9M.
Who is the CEO of LIFECORE BIOMEDICAL, INC. DE?
Mr. Paul Josephs is the chief executive officer of LIFECORE BIOMEDICAL, INC. DE (LFCR).
Get the full picture on LIFECORE BIOMEDICAL, INC. DE
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.